TRBJ2-7 |
A0A0A0MT78
|
T cell receptor beta joining 2-7
|
|
|
0.931 |
0.077 |
TRBV5-7 |
|
T cell receptor beta variable 5-7 (non-functional)
|
|
|
1.000 |
0.077 |
TRBJ2-1 |
A0A0A0MTA7
|
T cell receptor beta joining 2-1
|
|
|
1.000 |
0.077 |
LUNAR1 |
|
leukemia-associated non-coding IGF1R activator RNA 1
|
|
|
0.861 |
0.115 |
GNG8 |
Q9UK08
|
G protein subunit gamma 8
|
Enzyme modulator
|
0.16 |
0.931 |
0.115 |
NKG7 |
Q16617
|
natural killer cell granule protein 7
|
Cellular structure
|
1.5E-04 |
0.839 |
0.154 |
PLA2G4D |
Q86XP0
|
phospholipase A2 group IVD
|
Enzyme
|
2.6E-14 |
0.861 |
0.231 |
HBD |
|
hypophosphatemic bone disease
|
|
|
0.780 |
0.269 |
PWWP3A |
Q2TAK8
|
PWWP domain containing 3A, DNA repair factor
|
|
2.2E-03 |
0.636 |
0.385 |
TRGC1 |
P0CF51
|
T cell receptor gamma constant 1
|
|
|
0.663 |
0.385 |
BCL7A |
Q4VC05
|
BAF chromatin remodeling complex subunit BCL7A
|
|
7.8E-02 |
0.736 |
0.385 |
CD7 |
P09564
|
CD7 molecule
|
|
5.1E-02 |
0.722 |
0.385 |
ERVK-11 |
|
endogenous retrovirus group K member 11
|
|
|
0.663 |
0.423 |
ERVK-2 |
|
endogenous retrovirus group K member 2
|
|
|
0.674 |
0.423 |
ERVK-12 |
|
endogenous retrovirus group K member 12
|
|
|
0.678 |
0.423 |
ERVK-22 |
|
endogenous retrovirus group K member 22
|
|
|
0.678 |
0.423 |
KLK5 |
Q9Y337
|
kallikrein related peptidase 5
|
Enzyme
|
7.0E-03 |
0.623 |
0.462 |
SS18 |
Q15532
|
SS18 subunit of BAF chromatin remodeling complex
|
Nucleic acid binding
|
0.75 |
0.641 |
0.462 |
DNM3 |
Q9UQ16
|
dynamin 3
|
Enzyme modulator
|
2.4E-03 |
0.716 |
0.462 |
USP2 |
O75604
|
ubiquitin specific peptidase 2
|
Enzyme
|
6.9E-04 |
0.682 |
0.462 |
TCL1A |
P56279
|
T cell leukemia/lymphoma 1A
|
|
5.7E-10 |
0.558 |
0.500 |
TCL1B |
O95988
|
T cell leukemia/lymphoma 1B
|
|
1.0E-02 |
0.561 |
0.500 |
RHOF |
Q9HBH0
|
ras homolog family member F, filopodia associated
|
Enzyme modulator
|
1.8E-04 |
0.638 |
0.500 |
TARP |
|
TCR gamma alternate reading frame protein
|
|
|
0.638 |
0.500 |
INTS1 |
Q8N201
|
integrator complex subunit 1
|
|
7.1E-11 |
0.666 |
0.500 |